317.69 USD
↗ 0.14 (0.04%)LIVE (AS OF 03:22 PM EDT)
Shares of Penumbra, Inc. (PEN) are trading at $317.69. The stock presents a mixed profile: our models indicate a Buy for underlying fundamentals, while technical indicators flash a Strong Sell. Key drivers include a robust Altman Z-Score, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Furthermore, PEN is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Oct 2, 2026.
Open?$318.23
High?$318.40
Low?$317.52
Prev. Close?$317.55
Volume?187.7K
Avg. Volume?353.0K
VWAP?$317.95
Rel. Volume?0.53x
Bid / Ask
Bid?$317.70 × 40
Ask?$317.74 × 40
Spread?$0.04
Midpoint?$317.72
Valuation & Ratios
Market Cap?12.5B
Shares Out?39.4M
Float?38.2M
Float %?97.1%
P/E Ratio?77.89
P/B Ratio?8.17
EPS?$4.08
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.
Employees
4.7K
Market Cap
12.5B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2015-09-18
Address
ONE PENUMBRA PLACE
ALAMEDA, CA 94502
Phone: (510) 995-2486
ALAMEDA, CA 94502
Phone: (510) 995-2486
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookBuy
Strong SellNeutralStrong Buy
F-Score?60
Z-Score?100
Momentum?75
Short Sent.?42
Piotroski F-Score?5/9Mixed
Altman Z-Score?18.87Safe
Confidence?67%Moderate
Short InterestHigh
Short % of Float?4.73%Low
Short Interest?1.8M
Days to Cover?7.2
Free Float38.2M
Avg Daily Volume251.7K
Settlement Date2026-09-15
Financial Health
Current Ratio?5.75Strong
Quick Ratio?3.86Strong
Cash Ratio?0.88Adequate
Debt/Equity?0.01Low
ValuationRICHLY VALUEDvs 2 peers + S&P 500
Score33/100
P/E?77.9PRICEY▾
Peers33
S&P5
P/B?8.17HIGH▾
Peers33
S&P23
P/S?8.31HIGH▾
Peers33
S&P12
P/FCF?57.9PRICEY▾
Peers33
S&P8
EV/EBITDA?60.3HIGH▾
Peers33
S&P3
EV/Sales?8.19HIGH▾
Peers33
S&P16
Returns & Efficiency
ROE?10.5%FAIR▾
Peers67
S&P37
ROA?8.1%STRONG▾
Peers67
S&P66
Cash Flow & Enterprise
FCF?$215.9M
Enterprise Value?$12.3B
Fundamentals ratios updated end of day